Manikandan Subramanian: In Our Latest Study We Uncover a Key Mechanism Behind Clearance of Dying Cells Failure
Manikandan Subramanian, Group Leader and Deputy Director of Research at the William Harvey Research Institute, Barts and The London School of Medicine, shared a post on LinkedIn:
“Clearance of dying cells—lovingly called efferocytosis—is a vital housekeeping role carried out by macrophages. But when this process fails, tissues buckle under pressure of mounting debris and start to dysfunction. In diseases like atherosclerosis, this breakdown can ultimately trigger heart attacks and strokes.
In our latest study, published in Circulation Research and led by Aarushi Singhal we uncover a key mechanism behind this failure. We found that endoplasmic reticulum stress activates the protein TRIB3, which then blocks macrophages from forming the membrane structures needed to engulf and clear dead cells.
In other words, TRIB3 acts as a brake on efferocytosis in atherosclerotic plaques—and targeting it could open new therapeutic pathways for cardiovascular disease.
Title: TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in Atherosclerosis
Authors: Aarushi Singhal, Stefan Russo, Umesh Kumar Dhawan, Kunzangla Bhutia, Christopher G. Bell, Hedayatullah Hayat, Thomas D. Nightingale, Monica de Gaetano, Orina Belton, Eoin Brennan, Patricia B. Munroe, Catherine Godson, Mary Barry, Carol C. Shoulders, Heather L. Wilson, Guillermo Velasco, Endre Kiss-Toth, Manikandan Subramanian

Curious to learn more? Read the full paper here.
A huge thanks to Barts Charity and the British Heart Foundation for supporting this work, and to all our fantastic collaborators who made this possible.”
Stay updated with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
